• Citer

Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer.

par Marechal, Raphaël ;Demols, Anne ;Gay, France ;De Maertelaer, Viviane ;Arvanitakis, Marianna ;Hendlisz, Alain ;Van Laethem, Jean-Luc
Référence Pancreas, 36, 3, page (e16-e21)
Publication Publié, 2008-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer.
Auteur:	Marechal, Raphaël; Demols, Anne; Gay, France; De Maertelaer, Viviane; Arvanitakis, Marianna; Hendlisz, Alain; Van Laethem, Jean-Luc
Informations sur la publication:	Pancreas, 36, 3, page (e16-e21)
Statut de publication:	Publié, 2008-04
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Chemotherapy
	Elderly
	Neoplasms
	Pancreas
MeSH keywords:	Adenocarcinoma -- drug therapy -- mortality
	Adult
	Age Factors
	Aged
	Aged, 80 and over
	Antineoplastic Agents -- adverse effects -- therapeutic use
	Deoxycytidine -- adverse effects -- analogs & derivatives -- therapeutic use
	Drug Tolerance
	Humans
	Kaplan-Meier Estimate
	Middle Aged
	Pancreatic Neoplasms -- drug therapy -- mortality
	Prognosis
	Retrospective Studies
	Treatment Outcome
Note générale:	Clinical Trial, Phase II
	Clinical Trial, Phase III
	Journal Article
	Multicenter Study
Langue:	Anglais
Identificateurs:	urn:issn:0885-3177
	info:doi/10.1097/MPA.0b013e31815f3920
	info:pii/00006676-200804000-00024
	info:scp/41149162302
	info:pmid/18362833